- Home
- Managing Hypertension in CVD: How Low Can We Go?
Managing Hypertension in CVD: How Low Can We Go?
- Guidelines
- Prevention
Available Credit:
- 1.00
Course Published On:
Course Expiry Date:
Overview
This virtual educational programme offers a comprehensive CME-accredited course for healthcare professionals managing hypertension in patients with cardiovascular disease.
Chaired by Dr Yassir Javaid (Imperial College Healthcare NHS Trust, London, UK), with Prof Michel Burnier (University Hospital of Lausanne, Lausanne, CH), Prof Mariya Tokmakova (Medical University of Plovdiv, Plovdiv, BG) and Prof Reinhold Kreutz (Charite University Medicine, Berlin, DE), the expert faculty explores how to identify and classify very high-risk patients, interpret the CVD–hypertension link and apply current guideline-directed approaches, including the latest ESH recommendations.
Emerging questions in hypertension management are addressed, including the potential role of cardiovascular risk-driven treatment initiation, the evolving use of beta blockers and strategies to improve long-term adherence.
Support Statement
This programme is supported by an unrestricted educational grant from Merck Healthcare KGaA (Darmstadt, Germany).
Disclosure
In compliance with EBAC guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations.
The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities.
Terms & Conditions
Radcliffe Education requires contributors to our CME programmes to disclose any relevant financial relationships that have occurred within the past 12 months that could create a conflict of interest. These will be identified in the faculty section if applicable.
The session, ‘Managing Hypertension in CVD: How Low Can We Go?’ is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 hour of external CME credit.
Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).
Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website.
Instruction to Participants
There is no fee for taking part in this online learning activity.
Activities are designed to be completed within 60 minutes and must be completed by the registered user. Physicians should only claim credits for time spent on the activity. To successfully earn credit, participants must complete the activity in full in the indicated time frame.
To complete the course and claim certification participants must:
- Read the course outline information supplied and complete pre-test questions if supplied prior to starting the activity. Users must read and study the activity in its entirety before completing the post-test questions.
- Your results will be automatically saved and if a pass score is achieved (where applicable), you may be eligible to claim credit for the activity and receive a certificate of completion.
Target Audience
- Cardiologists
- Hypertension Specialists
- Primary Care Physicians
- Allied Healthcare Professionals Involved in Cardiovascular Care
Learning Objectives
Upon completion of this activity, participants will be able to:
- Describe the link between CVD and hypertension
- Classify hypertension patients according to their cardiovascular risk
- Recall recent guideline-directed and evidence-based strategies for managing very high CVD risk patients
- Apply guideline-directed and evidence-based management strategies to a case study
- Use expert guidance to adopt optimal multidisciplinary antihypertensive management strategies in patients with very high cardiovascular risk
Module |
Title |
Duration |
Speakers |
|---|---|---|---|
| Session 1 | Introduction | 4m 2s | Yassir Javaid Michel Burnier Mariya Tokmakova Reinhold Kreutz |
| Session 2 | Understanding and Defining the Link Between CVD and HTN | 11m 3s | Michel Burnier |
| Session 3 | Stratifying According to Risk and Outcome Data | 12m 27s | Mariya Tokmakova |
| Session 4 | Guideline-directed Management of Very High-risk Patients | 11m 39s | Reinhold Kreutz |
| Session 5 | Case Presentation and Discussion | 17m 35s | Yassir Javaid Michel Burnier Mariya Tokmakova Reinhold Kreutz |
Introduction
Duration: 4m 2s
Speakers: Yassir Javaid Michel Burnier Mariya Tokmakova Reinhold Kreutz
Guideline-directed Management of Very High-risk Patients
Duration: 11m 39s
Speakers: Reinhold Kreutz
Case Presentation and Discussion
Duration: 17m 35s
Speakers: Yassir Javaid Michel Burnier Mariya Tokmakova Reinhold Kreutz
Chair
Speaker
Managing Hypertension in CVD: How Low Can We Go?'s programme has been accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 CME point, equating to 1 hour of learning. Physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™.